Glucagon NDC 63323-593

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-593Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0593Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-593-03	63323059303	1 KIT in 1 CARTON (63323-593-03) * 1 mL in 1 VIAL, SINGLE-DOSE (63323-596-03) * 1 mL in 1 VIAL, SINGLE-DOSE (63323-185-03)Marketed from May 8, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glucagon
Generic name (nonproprietary): glucagon
Dosage form: Kit
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 201849
Marketing start: May 8, 2015
Listing expires: Dec 31, 2026
Identifiers: Product ID 63323-593_eb37fc8a-a264-4ce9-a130-466e9b5f3a38SPL ID eb37fc8a-a264-4ce9-a130-466e9b5f3a38SPL set ID e4be1c0e-0fe6-45a0-9229-5cde98434b84RxCUI 310497UNII 1H87NVF4DBUPC 0363323596033

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N463323059303 followed by a unit qualifier and the quantity

Package 63323-0593-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 16, 2020.

Indications (excerpt from the label)

Glucagon for Injection is an antihypoglycemic agent and a gastrointestinal motility inhibitor indicated: for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ( 1.1 ) as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients ( 1.2 ) 1.1 Severe Hypoglycemia Glucagon for Injection is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. 1.2 Diagnostic Aid Glucagon for Injection is indicated as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients.…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 201849

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 201849
Product	Strength	Form · route	Labeler	Product NDC
Glucagon	—	Kit	Fresenius Kabi USA, LLC	63323-582
Glucagon	Glucagon hydrochloride 1 mg/mL	Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-596
Glucagon	—	Kit	Fresenius Kabi USA, LLC	63323-594
Glucagon	Glucagon hydrochloride 1 mg/mL	Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous	Fresenius Kabi USA, LLC	63323-596
Glucagon	—	KitIntramuscular, Intravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1498